Status
Conditions
Treatments
About
The purpose of this study is to collect information about people with fibrolamellar cancer (FLC). This study is a registry of people with FLC around the world. This study will involve collecting information about participants, their medical history and the regular medical care they receive for FLC. The study will not provide treatment for your cancer.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Age 13 years or older.
Personal history of histologically proven fibrolamellar carcinoma (clinical or radiographical suspicion of FLC must be confirmed at MSK or an external hospital)
Participants must have access to electronic devices that meet the following minimum requirements:
Participants must have a google account
Exclusion criteria
100 participants in 1 patient group
Loading...
Central trial contact
Imane El Dika, MD; Ghassan Abou-Alfa, MD, MBA
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal